CYTONICS

Cytonics engages in PC-controlled micropattern light irradiation device and photoresponsive cell culture dish. It was established on 2007 Decembers 12.

#SimilarOrganizations #People #Website #More

CYTONICS

Industry:
Health Care Medical Medical Device

Founded:
2007-12-12

Address:
Matsumoto, Nagano, Japan

Country:
Japan

Website Url:
http://www.cytonics.jp

Status:
Closed


Similar Organizations

apsun-logo

Apsun

Apsun engages in rehabilitation medical devices and products.

taryag-medical-logo

Taryag Medical

Taryag Medical is a medical device company that develops and manufactures invasive vascular devices.

Current Employees Featured

not_available_image

Masumi Yanagisawa
Masumi Yanagisawa CEO @ Cytonics
CEO

Official Site Inspections

http://www.cytonics.jp

Unable to get host informations!!!

Loading ...

More informations about "Cytonics"

Home - New - Cytonics Corporation

Cytonics has received over $15M in funding to-date, including $1.8M in grants from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). โ€ฆSee details»

Management - Cytonics Corporation

Cytonics has received over $25M in funding to date, including $1.8M from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). Now, we are raising capital from both non-accredited and โ€ฆSee details»

Cytonics - Crunchbase Company Profile & Funding

Cytonics engages in PC-controlled micropattern light irradiation device and photoresponsive cell culture dish. It was established on 2007 Decembers 12. Lists Featuring This CompanySee details»

Cytonics 2025 Company Profile: Valuation, Funding

Cytonics has raised $34.2M. Who are Cytonicsโ€™s investors? River VC, The Rainmakers ( Application Software) , DePuy Synthes , National Institutes of โ€ฆSee details»

About - Cytonics Corporation

Cytonics is a privately held biotechnology company specializing in the development of diagnostics and therapeutics for osteoarthritis (OA), a disease of the joints that renders the afflicted โ€ฆSee details»

#6 Meet The Cytonics Triumvirate - Cytonics Corporation

Jan 2, 2024 In the competitive world of biopharmaceutical R&D, Cytonics is taking on Big Pharma in the fight against osteoarthritis. Led by Dr. Gaetano Scuderi, Joey Bose, and Dr. Lewis Hanna, they bring a unique blend of clinical โ€ฆSee details»

Cytonics

Cytonics is a clinical stage company tackling one of the most destructive diseases the world has ever known: osteoarthritis. With over $25M invested in research and development, a portfolio โ€ฆSee details»

#28 โ€ The Business of Biotech (4th ... - Cytonics โ€ฆ

May 1, 2024 The CEO of Cytonics, Joey Bose, navigates a day filled with challenges in spearheading the companyโ€™s mission. From managing emails and operations to engaging in international collaboration and physical activities, his โ€ฆSee details»

Cytonics Co., Ltd. - Products, Competitors, Financials, Employees ...

Cytonics.jp. Overview & Products; About Cytonics Co., Ltd. Provider of cell engineering services. The company is engaged in cell engineering, optic cell manipulation and research. The โ€ฆSee details»

Cytonics - Crunchbase Company Profile & Funding

Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan Complex Test (FACT) for molecular discography and FACT Plus multi analyte assay for โ€ฆSee details»

Technology - Cytonics Corporation

We have contracted a research organization, Goodwin Biotechnology, to purify industrial-scale quantities of CYT-108 for pre-clinical experiments and FDA clinical trials. Keys to Success. โ€ฆSee details»

#46 Critical Patent Issuance Protecting Lead Drug Candidate

Mar 8, 2025 Cytonics Corporation has received US Patent No. US 12,195,521 B2 for its engineered A2M variant, CYT-108. This patent enhances its competitive position by expanding โ€ฆSee details»

Cytonics - Contacts, Employees, Board Members, Advisors & Alumni

Cytonics is a biotechnology company developing diagnostic assays focusing on musculoskeletal-related pain. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. โ€ฆSee details»

Cytonics on StartEngine 2025 - Kingscrowd

Cytonics has created an Autologous Platelet Integrated Concentration system concentrating A2M from patientsโ€™ blood to treat their own damaged joints. The company has a strong IP portfolio โ€ฆSee details»

cytonics.com Reviews: Is this site a scam or legit?

This term indicates whether cytonics.com has landed on any online directories' blacklists and earned a suspicious tag. Assessing HTTPS Connectivity. This section provides insight into โ€ฆSee details»

News - Cytonics Corporation

Mar 4, 2019 Cytonics has received over $25M in funding to date, including $1.8M from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson โ€ฆSee details»

Cytonics Corporation โ€“ In this blog series, we will illuminate โ€ฆ

Cytonics has completed its first-in-human trial for CYT-108, a recombinant protease inhibitor for knee osteoarthritis. The 22-patient Phase 1 study focused on safety and efficacy, providing โ€ฆSee details»

Cytonics - Crunchbase

Organization. Cytonics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. โ€ฆSee details»

Thursday, April 3, 2025 (Scores) Lotte vs ORIX | NPB.jp ๆ—ฅๆœฌ้‡Ž็ƒๆฉŸๆง‹

2 days ago ๆ—ฅๆœฌ้‡Ž็ƒๆฉŸๆง‹๏ผˆnpb๏ผ‰ใ‚ชใƒ•ใ‚ฃใ‚ทใƒฃใƒซใ‚ตใ‚คใƒˆใ€‚ใƒ—ใƒญ้‡Ž็ƒ12็ƒๅ›ฃใฎ่ฉฆๅˆๆ—ฅ็จ‹ใƒป็ตๆžœใ‚„ไบˆๅ‘Šๅ…ˆ็™บใ€ใƒ‰ใƒฉใƒ•ใƒˆไผš่ญฐใ‚’ใฏใ˜ใ‚ใ€ไบ‹ๆฅญใƒปๆŒฏ่ˆˆใซ้–ขใ™ใ‚‹ๆƒ…ๅ ฑใ‚’ๆŽฒ่ผ‰ใ€‚ใพใŸใ€ใ‚ชใƒผใƒซใ‚นใ‚ฟใƒผ๏ฝฅ โ€ฆSee details»

FAQ - Cytonics Corporation

Cytonics has received over $25M in funding to date, including $1.8M from the National Institute of Health and a $4M investment from Synthes (a Johnson and Johnson company). Now, we are โ€ฆSee details»

linkstock.net © 2022. All rights reserved